InvestorLens

CAI — CARIS LIFE SCIENCES INC

Public company

Sign in to save5 tracked investors reported this
For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

Why are billionaires buying CAI?

Built from public SEC filings and public economic data. Not a recommendation.

Confidence
50
Institutional Conviction
Net distribution · 1 buying vs 1 selling last quarter
38
Macro Tailwind
Macro conditions are mixed for this sector
56
Why? — Evidence & Confidence ▾

Of 2 tracked investors who changed their CAI position last quarter, 1 bought and 1 sold (50% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 56/100 in a Overheat regime).

Supporting evidence
  • +1 tracked investor added or increased positions last quarter (Izzy Englander)
  • +5 tracked investors reported holding CAI at their latest filing
  • +Macro Health is 56/100 in a Overheat regime — historically acceptable for this sectorsource
Contradicting evidence — always shown
  • −1 tracked investor reduced or exited last quarter (0 reduced, 1 sold out)
  • −13F data is disclosed up to 45 days after quarter end — positions may have changed since
Know the limits
  • · 13F disclosure lag (up to 45 days)
  • · Tracked investors are a sample, not the whole market
  • · Sector regime fit is a historical average, not a guarantee

Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 9/18/2026.

About CARIS LIFE SCIENCES INC (CAI)

CARIS LIFE SCIENCES INC (CAI) appears in the most recent 13F filings of 5 tracked institutional investors. The largest disclosed position is held by Philippe Laffont (Coatue Management), valued at $307M. Across recent filings, tracked investors recorded 7 new positions, 4 increased, 6 reduced, and 3 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in CAI

55
/100
Mixed Activity
Added / Increased11
Reduced6
Exited3
BearishBullish
Crowded Trade Score™

How many top investors track CAI

33
/100
Emerging Interest
5investors

A small number of top investors own this.

UndiscoveredCrowded
151015+

CAI Ownership Composition

How CARIS LIFE SCIENCES INC is held across tracked investor types, based on reported 13F positions.

Dominant Type
Growth & Innovation
68% of tracked value
Institutions
5
tracked investors
Total Reported
$256.8M
combined 13F value
Types3
  • Growth & Innovation68.1%
  • Multi-Strategy / Quant18.0%
  • Macro13.8%
Growth & Innovation(1)
68.1%
Multi-Strategy / Quant(2)
18.0%
Macro(2)
13.8%

Tracked investors currently reporting CAI

3 tracked investors have since exited this position — listed separately below.

  • Philippe LaffontJun 30, 2026
    Coatue Management
    Shares
    9.8M
    Value
    $175M
    % Portfolio
    0.36%
  • Izzy EnglanderJun 30, 2026
    Millennium Management
    Shares
    2.2M
    Value
    $39.3M
    % Portfolio
    0.01%
  • Ken GriffinJun 30, 2026
    Citadel Advisors
    Shares
    394.7K
    Value
    $7M
    % Portfolio
    0.00%
  • Stanley DruckenmillerJun 30, 2026
    Duquesne Family Office
    Shares
    1.9M
    Value
    $33.8M
    % Portfolio
    0.65%
  • Paul Tudor JonesJun 30, 2026
    Tudor Investment Corp
    Shares
    100.3K
    Value
    $1.8M
    % Portfolio
    0.00%

Previously held CAI

These investors reported CAI in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.

InvestorFirmLast reported sharesValue thenLast held
Steve CohenPoint72 Asset Management918.3K$16.4MMar 31, 2026
Cathie WoodARK Investment Management408.7K$11MDec 31, 2025
George SorosSoros Fund Management55.7K$1.7MSep 30, 2025

Recent activity

Frequently asked questions

How many institutional investors hold CAI?
5 tracked institutional investors disclosed a position in CAI (CARIS LIFE SCIENCES INC) in their most recent 13F filing.
Who is the largest institutional holder of CAI?
Philippe Laffont, Coatue Management, holds the largest disclosed position in CAI, valued at $307M.
Did institutional ownership of CAI increase or decrease?
Across recent 13F filings, tracked investors recorded 7 new positions, 4 increased, 6 reduced, and 3 fully exited CAI.
Where does this CAI ownership data come from?
SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.